Progressive Interstitial Lung Disease in a Clinically Quiescent Dermatomyositis

Authors

  • Jan Michael Jesse C. Lomanta Division of Pulmonary Medicine, Philippine General Hospital, University of the Philippines Manila
  • Milraam L. Quinto Division of Pulmonary Medicine, Philippine General Hospital, University of the Philippines Manila; Department of Medicine, St. Luke’s Medical Center, Bonifacio Global City
  • Sheen C. Urquiza Department of Radiology, Philippine General Hospital, University of the Philippines Manila
  • Charito Cruz-Bermudez Rheumatology, Allergology and Immunology Center, St. Luke’s Medical Center, Quezon City
  • Joel M. Santiaguel Division of Pulmonary Medicine, Philippine General Hospital, University of the Philippines Manila; Department of Medicine, Quirino Memorial Medical Center, Quezon City

DOI:

https://doi.org/10.47895/amp.vi0.4693

Keywords:

dermatomyositis, interstitial lung disease, immunomodulator

Abstract

A 60-year-old Filipino woman diagnosed with dermatomyositis was initially on prednisone and methotrexate. She eventually developed interstitial lung disease (ILD) and so methotrexate was shifted to azathioprine; however, azathioprine was discontinued due to cutaneous tuberculosis. Over eight years, the dermatomyositis was controlled by prednisone alone but the ILD worsened. This case demonstrated that the course of ILD may be independent of dermatomyositis.



Downloads

Published

2023-04-28

Issue

Vol. 57 No. 4 (2023)

Section

Articles

How to Cite

1.
Progressive Interstitial Lung Disease in a Clinically Quiescent Dermatomyositis. Acta Med Philipp [Internet]. 2023 Apr. 28 [cited 2025 Apr. 3];57(4). Available from: https://actamedicaphilippina.upm.edu.ph/index.php/acta/article/view/4693

Most read articles by the same author(s)